Communicable disease threats report, 16-22 February 2020, week 8
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 February 2020 and includes updates on chikungunya, dengue, Ebola virus disease, COVID-19, polio, seasonal influenza and polio.
HIV and migrants: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
Active tuberculosis case finding in migrants – ECDC workshop for EU Member States
On 18 and 19 February 2022, the European Centre for Disease Prevention and Control (ECDC) organised a workshop on tuberculosis (TB) case finding in migrants in Athens, Greece.
Seminar about the coronavirus
How is the coronavirus outbreak affecting Europe and Sweden and which counter measures are being taken? ECDC’s Director Andrea Ammon will explain the current rapidly evolving situation and what is being done at the European level. DG Johan Carlson from Folkhälsomyndigheten will explain what is the situation in Sweden.
Rapid risk assessment: Increase in OXA -244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
Interim guidance for environmental cleaning in non-healthcare facilities exposed to SARS-CoV-2
This document aims to provide guidance about the environmental cleaning in non-healthcare facilities (e.g. rooms, public offices, transports, schools, etc.) where confirmed COVID-19 cases have been before being admitted to hospital. This guidance is based on the current knowledge about SARS-CoV-2 and evidence originating from studies on other coronaviruses.
Are European laboratories ready to detect COVID-19?
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
Risk assessment: Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China – fourth update
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade. The novel coronavirus has thus been named ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2), while coronavirus disease associated with it is now referred to as COVID-19.